Esteban-Amo M, Telleria A, Gobelli D, Serrano-Lorenzo P, Telleria J, Perez-Garcia M
BMC Res Notes. 2025; 18(1):83.
PMID: 40001192
PMC: 11863808.
DOI: 10.1186/s13104-025-07149-8.
Zhang X, Zheng C, Ge W, Li X, Wang X, Sun Y
PeerJ. 2025; 13:e18961.
PMID: 39963196
PMC: 11831975.
DOI: 10.7717/peerj.18961.
Valeros J, Jerome M, Tseyang T, Vo P, Do T, Fajardo Palomino D
Cell. 2025; 188(4):1084-1099.e27.
PMID: 39909039
PMC: 11845293.
DOI: 10.1016/j.cell.2024.12.007.
osz F, Nazir A, Takacs-Vellai K, Farkas Z
Antioxidants (Basel). 2025; 14(1).
PMID: 39857410
PMC: 11761250.
DOI: 10.3390/antiox14010076.
He C, Chen P, Ning L, Huang X, Sun H, Wang Y
Inflammation. 2025; .
PMID: 39806091
DOI: 10.1007/s10753-024-02207-y.
Dietary RNA from Torula Yeast Prevents Capillary Regression in Atrophied Skeletal Muscle in Rats.
Lin H, Xing J, Ma X, Nakanishi R, Kondo H, Fujita M
Life (Basel). 2025; 14(12.
PMID: 39768324
PMC: 11679692.
DOI: 10.3390/life14121616.
Similar deficiencies, different outcomes: succinate dehydrogenase loss in adrenal medulla vs. fibroblast cell culture models of paraganglioma.
Al Khazal F, Mahadev Bhat S, Zhu Y, de Araujo Correia C, Zhou S, Wilbanks B
Cancer Metab. 2024; 12(1):39.
PMID: 39716277
PMC: 11668036.
DOI: 10.1186/s40170-024-00369-9.
Unveiling the roles of in : Implications for virulence and azole resistance.
Huang M, Song D, Zhou L, Jiao Z, Yang L, Yang Y
Virulence. 2024; 15(1):2405000.
PMID: 39403939
PMC: 11485852.
DOI: 10.1080/21505594.2024.2405000.
Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme.
Esteban-Amo M, Jimenez-Cuadrado P, Serrano-Lorenzo P, de la Fuente M, Simarro M
Biomedicines. 2024; 12(9).
PMID: 39335562
PMC: 11429145.
DOI: 10.3390/biomedicines12092050.
SDHA-related phaeochromocytoma and paraganglioma: review and clinical management.
Kaplan A, Dwight T, Luxford C, Benn D, Clifton-Bligh R
Endocr Relat Cancer. 2024; 31(10).
PMID: 39133175
PMC: 11466202.
DOI: 10.1530/ERC-24-0111.
Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry.
Abir A, Weckwerth L, Wilhelm A, Thomas J, Reichardt C, Munoz L
Mol Metab. 2024; 87:101981.
PMID: 38971403
PMC: 11300934.
DOI: 10.1016/j.molmet.2024.101981.
node2vec2rank: Large Scale and Stable Graph Differential Analysis via Multi-Layer Node Embeddings and Ranking.
Mandros P, Gallagher I, Fanfani V, Chen C, Fischer J, Ismail A
bioRxiv. 2024; .
PMID: 38948759
PMC: 11212899.
DOI: 10.1101/2024.06.16.599201.
Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention.
Huang H, Li G, He Y, Chen J, Yan J, Zhang Q
Front Immunol. 2024; 15:1404441.
PMID: 38933270
PMC: 11200920.
DOI: 10.3389/fimmu.2024.1404441.
The bioenergetic landscape of cancer.
Zunica E, Axelrod C, Gilmore L, Gnaiger E, Kirwan J
Mol Metab. 2024; 86:101966.
PMID: 38876266
PMC: 11259816.
DOI: 10.1016/j.molmet.2024.101966.
Heterogeneous distribution of mitochondria and succinate dehydrogenase activity in human airway smooth muscle cells.
Mahadev Bhat S, Sieck G
FASEB Bioadv. 2024; 6(6):159-176.
PMID: 38846375
PMC: 11150758.
DOI: 10.1096/fba.2024-00047.
A myzozoan-specific protein is an essential membrane-anchoring component of the succinate dehydrogenase complex in parasites.
Zwahlen S, Hayward J, Maguire C, Qin A, van Dooren G
Open Biol. 2024; 14(6):230463.
PMID: 38835243
PMC: 11285852.
DOI: 10.1098/rsob.230463.
Niacin supplementation attenuates the regression of three-dimensional capillary architecture in unloaded female rat skeletal muscle.
Lin H, Xing J, Pan H, Hirabayashi T, Maeshige N, Nakanishi R
Physiol Rep. 2024; 12(8):e16019.
PMID: 38627220
PMC: 11021194.
DOI: 10.14814/phy2.16019.
Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia.
Fabozzi F, Carrozzo R, Lodi M, Di Giannatale A, Cipri S, Rosignoli C
Front Oncol. 2024; 13:1324013.
PMID: 38260858
PMC: 10800918.
DOI: 10.3389/fonc.2023.1324013.
Tryptophan Prevents the Development of Non-Alcoholic Fatty Liver Disease.
Yanko R, Levashov M, Chaka O, Nosar V, Khasabov S, Khasabova I
Diabetes Metab Syndr Obes. 2023; 16:4195-4204.
PMID: 38152280
PMC: 10752026.
DOI: 10.2147/DMSO.S444278.
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline pathogenic variant in the absence of paraganglioma or pheochromocytoma.
Alzahrani A, Bin Nafisah A, Alswailem M, Moria Y, Poprawski D, Al-Hindi H
Front Endocrinol (Lausanne). 2023; 14:1273093.
PMID: 38152133
PMC: 10751293.
DOI: 10.3389/fendo.2023.1273093.